Luteal phase support with estrogen in addition to progesterone increases pregnancy rates in in vitro fertilization cycles with poor response to gonadotropins

References

• Aboulghar M. Luteal support in reproduction: when, what and how? Curr Opin Obstet Gynecol 2009;21:279–84
   PubMedGoogle Scholar
• Van der Linden M, Buckingham K, Farquhar C, et al. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2011:CD009154
   Google Scholar
• Hutchinson-Williams KA, Lunenfeld B, Diamond MP, et al. Human chorionic gonadotropin, estradiol, and progesterone profiles in conception and nonconception cycles in an in vitro fertilization program. Fertil Steril 1989;52:441–5
   PubMed Web of Science ®Google Scholar
• Sharara FI, McClamrock HD. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome. Hum Reprod 1999;14:2777–82
   PubMed Web of Science ®Google Scholar
• Jee BC, Suh CS, Kim SH, et al. Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis. Fertil Steril 2010;93:428–36
   PubMed Web of Science ®Google Scholar
• Ferraretti AP, La Marca A, Fauser BCJM, et al. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–24
   PubMed Web of Science ®Google Scholar
• Fujimoto A, Osuga Y, Fujiwara T, et al. Human chorionic gonadotropin combined with progesterone for luteal support ımproves pregnancy rate in patients with low late-midluteal estradiol levels in IVF cycles. J Assist Reprod Genet 2002;19:550–4
   PubMed Web of Science ®Google Scholar
• Chang EM, Han JE, Won HJ, et al. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization. J Assist Reprod Genet 2012;29:225–30
   PubMed Web of Science ®Google Scholar
• Frattarelli JL, McWilliams GDE, Hill MJ, et al. Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders. Fertil Steril 2008;89:1113–17
   PubMed Web of Science ®Google Scholar
• Smitz J, Devroey P, Camus M, et al. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. Hum Reprod 1988;3:585–90
   PubMed Web of Science ®Google Scholar
• Smitz J, Erard P, Camus M, et al. Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. Hum Reprod 1992;7:1225–9
   PubMed Web of Science ®Google Scholar
• Fauser BCJM, Devroey P. Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends Endocrinol Metab 2003;14:236–42
   PubMed Web of Science ®Google Scholar
• Edgar DH. Oestrogen and human implantation. Hum Reprod 1995;10:2–4
   PubMedGoogle Scholar
• Hubayter ZR, Muasher SJ. Luteal supplementation in in vitro fertilization: more questions than answers. Fertil Steril 2008;89:749–58
   PubMed Web of Science ®Google Scholar
• Nippoldt TB, Reame NE, Kelch RP, Marshall JC. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab 1989;69:67–76
   PubMed Web of Science ®Google Scholar
• Aghahosseini M, Aleyassin A, Khodaverdi S, et al. Estradiol supplementation during the luteal phase in poor responder patients undergoing in vitro fertilization: a randomized clinical trial. J Assist Reprod Genet 2011;28:785–90
   PubMed Web of Science ®Google Scholar
• Muasher S, Acosta AA, Garcia JE, et al. Luteal phase serum estradiol and progesterone in in vitro fertilization. Fertil Steril 1984;41:838–43
   PubMedGoogle Scholar
• Ganesh A, Goswami S, Chattopadhyay R, et al. Luteal phase estradiol level: a potential predictive marker for successful pregnancy in in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2009;91:1018–22
   PubMed Web of Science ®Google Scholar
• Aktan E, Bozkurt K, Ozer D, et al. The effect of mid-luteal estradiol level on the outcome of ICSI-ET cycles. Arch Gynecol Obstet 2004;269:134–8
   PubMedGoogle Scholar
• Benadiva CA, Metzger DA. Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony. Fertil Steril 1994;61:700–4
   PubMed Web of Science ®Google Scholar